Sky-high drug prices for rare diseases show why Orphan Drug Act needs reform
Year: 2017
Type: other
Authors: Dana Goldman, Jay Bhattacharya
Institutions: University of Southern California, Stanford University
Language: English
Subfield: Economics and Econometrics
Domain: Social Sciences
Open Access status: closed
OpenAlex ID: W4413618686